Germany
Boehringer Ingelheim is a German company headquartered in Ingelheim and founded in 1885 by Albert Boehringer, still owned by the Boehringer and von Baumbach families after more than a century. The company focuses on cardio-metabolic disease, oncology, respiratory medicine and animal health.
Boehringer quietly developed Jardiance into one of the most important diabetes drugs of the decade, and with no external shareholders it operates without quarterly earnings pressure.
